✦ LIBER ✦

Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome

✍ Scribed by Birgit Högl; Diego Garcia-Borreguero; Claudia Trenkwalder; Luigi Ferini-Strambi; Wayne Hening; Werner Poewe; Stefanie S. Brenner; Mandy Fraessdorf; Michael Busse; Stefan Albrecht; Richard P. Allen

Book ID: 116885032
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 342 KB
Volume: 12
Category: Article
ISSN: 1389-9457
DOI: 10.1016/j.sleep.2010.12.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1.288 Patient-rated efficacy of pramipex

1.288 Patient-rated efficacy of pramipexole for restless legs syndrome: Results from three double-blind trials

✍ S. Albrecht; J. Koester 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Efficacy of pramipexole in restless legs

Efficacy of pramipexole in restless legs syndrome: A six-week, multicenter, randomized, double-blind study (effect-RLS study)

✍ Wolfgang H. Oertel; Karin Stiasny-Kolster; Bettina Bergtholdt; Yngve Hallström; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Abstract We evaluated the efficacy of pramipexole versus placebo in restless legs syndrome (RLS) for 6 weeks. Overall, 345 patients were randomly assigned in a 1:2 ratio to receive either placebo (n = 115) or pramipexole (n = 230) with a starting dose of 0.125 mg/day. The dose was individually o

Efficacy and safety of pramipexole in Ja

Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study

✍ Yuichi Inoue; Koichi Hirata; Kenji Kuroda; Masahiko Fujita; Tetsuo Shimizu; Naru 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 212 KB

P0022 Types and time-course of adverse e

P0022 Types and time-course of adverse events in 3 double-blind trials of pramipexole for restless legs syndrome

✍ W. Hening; J. Koester 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Efficacy and safety of pramipexole in ch

Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: Results from a multi-center, randomized, double-blind, placebo-controlled trial

✍ Jian-Fang Ma; Qi Wan; Xin-Yue Hu; Sheng-Gang Sun; Wei-Zhi Wang; Zhong-Xin Zhao; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 181 KB

P481 Clinician ratings and patient self-

P481 Clinician ratings and patient self-ratings of improvement after 3 weeks of double-blind placebo-controlled pramipexole for restless legs syndrome (RLS)

✍ Markku Partinen; Kari Hirvonen; Leni Jama; Anniina Alakuijala; Christer Hublin; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Efficacy and augmentation during 6&#xa0;months of double-blind pramipexole for restless legs syndrome

Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome